10579

524404

MARKSANS

img img img img
No Data Available

Marksans Pharma Share Price Update

As of the latest trading session, Marksans Pharma share price is currently at ₹176.14, which is down by ₹-2.33 from its previous closing. Today, the stock has fluctuated between ₹171.50 and ₹178.25. Over the past year, Marksans Pharma has achieved a return of [-]%. In the last month alone, the return has been [-]%.

Marksans Pharma performance

Today’s low

Today’s high

₹ 171.50 ₹ 178.25
₹ .00

52 week low

52 week high

₹ 155.00 ₹ 270.70
₹ .00

Open Price

₹ 173.00

Prev. Close

₹ 178.48

Volume (Shares)

.00

Total traded value

₹ .00

Upper Circuit

₹ 209.97

Lower Circuit

₹ 139.99

info

Marksans Pharma fundamentals


  • Market cap (Cr)

    0.0

  • P/E Ratio (TTM)

    0.0

  • Beta

    0.0

  • Book Value / share

    0.0

  • Return on equity

    0.0%

  • EPS (TTM)

    0.0

  • Dividend yield

    0.0%

  • Net profit/quarter (Cr)

    0.0

info icon alternate text
  • Market cap (Cr)

    7,436.40

  • P/E Ratio (TTM)

    30.30

  • Beta

    1.18

  • Book Value / share

    32.99

  • Return on equity

    14.45%

  • EPS (TTM)

    5.44

  • Dividend yield

    0.0%

  • Net profit/quarter (Cr)

    60.91

info icon alternate text

Marksans Pharma Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High

Marksans Pharma shareholding pattern

Holding

Name Shares Category

News

Left Arrow
Right Arrow

Marksans Pharma Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
0.0 0.0 redarrow
red-green-graph indicator
0 Bearish
0 Bullish
  • 5 Days 0.0
  • 26 Days 0.0
  • 10 Days 0.0
  • 50 Days 0.0
  • 12 Days 0.0
  • 100 Days 0.0
  • 20 Days 0.0
  • 200 Days 0.0
0.0 PIVOT

First Support

0.0

First Resistance

0.0

Second Support

0.0

Second Resistance

0.0

Third Support

0.0

Third Resistance

0.0

RSI

0.0

ADX

0.0

MACD

0.0

Williams % R

0.0

Commodity Channel Index (CCI)

0.0

Date

[-]

Week

0.0

Same Day

0.0

Month

0.0

1 Year

0.0

3 Year

0.0

Over 1 Month

0.0%

down

Over 1 Year

0.0%

down

Over 3 Months

0.0%

down

Over 3 Years

0.0%

down

Over 6 Months

0.0%

down

Over 5 Years

0.0%

down

Marksans Pharma Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
01 Aug 2025 0.8 Final 01 Aug 2025 Equity shares
17 Sep 2024 0.6 Final 17 Sep 2024 Equity shares
07 Jun 2023 0.5 Final 07 Jun 2023 Equity shares
19 Aug 2022 0.25 Final 23 Aug 2022 Equity shares
15 Sep 2021 0.25 Final 17 Sep 2021 Equity shares
22 Sep 2020 0.1 Final 24 Sep 2020 Equity shares
19 Sep 2019 0.05 Final 21 Sep 2019 Equity shares
19 Sep 2018 0.05 Final 22 Sep 2018 Equity shares
19 Sep 2017 0.05 Final 21 Sep 2017 Equity shares
22 Sep 2016 0.12 Final 24 Sep 2016 Equity shares
23 Sep 2015 0.12 Final 26 Sep 2015 Equity shares
18 Sep 2014 0.1 Final 20 Sep 2014 Equity shares
Ex-Date Old FV NEW FV Record Date
11 Mar 2008 10.0 1.0 18 Mar 2008
Dividend date Dividend amount Dividend type Record date Instrument type
01 Aug 2025 0.8 Final 01 Aug 2025 Equity shares
17 Sep 2024 0.6 Final 17 Sep 2024 Equity shares
07 Jun 2023 0.5 Final 07 Jun 2023 Equity shares
19 Aug 2022 0.25 Final 23 Aug 2022 Equity shares
15 Sep 2021 0.25 Final 17 Sep 2021 Equity shares
22 Sep 2020 0.1 Final 24 Sep 2020 Equity shares
19 Sep 2019 0.05 Final 21 Sep 2019 Equity shares
19 Sep 2018 0.05 Final 22 Sep 2018 Equity shares
19 Sep 2017 0.05 Final 21 Sep 2017 Equity shares
22 Sep 2016 0.12 Final 24 Sep 2016 Equity shares
23 Sep 2015 0.12 Final 26 Sep 2015 Equity shares
18 Sep 2014 0.1 Final 20 Sep 2014 Equity shares
Ex-Date Old FV NEW FV Record Date
11 Mar 2008 10.0 1.0 18 Mar 2008

Top Gainers

Marksans Pharma Share Result Highlights

Particulars

Sep 2024 (₹ in Cr)

Jun 2024 (₹ in Cr)

Mar 2024 (₹ in Cr)

Dec 2023 (₹ in Cr)

Sep 2023 (₹ in Cr)

Revenue

308.63

254.53

225.20

241.36

204.67

Operating Expense

263.65

220.38

198.98

208.09

176.10

Net Profit

63.20

32.02

32.99

25.29

31.29

Net Profit Margin (%)

20.47

12.58

14.64

10.47

15.28

Earnings Per Share (₹)

1.39

0.71

0.73

0.56

0.69

EBITDA

83.64

49.42

46.09

43.30

53.23

Effective Tax Rate (%)

17.19

24.30

14.08

26.90

29.68

Key Highlights:

  • Revenue Growth: Revenue grew significantly in Sep 2024 to ₹308.63 Cr from ₹204.67 Cr in Sep 2023.
  • Strong Profit Performance: Net profit increased to ₹63.20 Cr with a 20.47% margin.
  • Earnings Per Share (EPS): The EPS surged to ₹1.39 in Sep 2024.
  • Operating Efficiency: Operating expenses grew slower than revenue, improving margins.
  • The Marksans Pharma share price has shown positive results, reflecting the growth in key financial metrics.

Marksans Pharma Share Annual Reports

Particulars

Mar 2024 (₹ in Cr)

Mar 2023 (₹ in Cr)

Revenue

853.27

732.00

Operating Expense

743.46

650.23

Net Profit

133.76

112.65

Net Profit Margin (%)

15.67

15.39

Earnings Per Share (₹)

2.95

2.50

EBITDA

202.01

180.52

Effective Tax Rate (%)

22.18

20.50

Key Highlights:

  • Revenue Growth: Revenue increased by approximately ₹121.27 Cr from ₹732.00 Cr in FY 2022-23.
  • Profitability: The net profit grew to ₹133.76 Cr in FY 2023-24 with a 15.67% margin.
  • Strong EPS Performance: Earnings per share rose to ₹2.95.
  • Operational Efficiency: EBITDA grew by ₹21.49 Cr, reflecting improved operational efficiency.
  • The annual financial performance has had a positive impact on the Marksans Pharma share price, reflecting steady growth in revenue and profits.

Marksans Pharma Share Dividend

Particulars

Ex-Date

Record Date

Dividend per Share (₹)

07 Jun, 2023

07 Jun, 2023

Dividend Yield (%)

0.5

Equity Shares

Key Highlights:

  • Consistent Payouts: Marksans Pharma has regularly paid dividends, with the latest payout of ₹0.5 per share in June 2023.
  • Shareholder Returns: Dividend yields have been consistent, offering moderate returns to shareholders.
  • Final Dividends: Recent payouts have been final dividends, reflecting the company’s strong profit performance.
  • The dividend payouts complement the overall performance of the Marksans Pharma share price, providing additional value to investors.
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Marksans Pharma Ltd?

Answer Field

Marksans Pharma Ltd share price is for NSE ₹ 176.14 & for BSE ₹ 176.15 as on Apr 13 2026 03:30 PM.

What is the Market Cap of Marksans Pharma Ltd Share?

Answer Field

The market cap of Marksans Pharma Ltd for NSE ₹ 7,430.50 & for BSE ₹ 0.00 as on Apr 13 2026 03:30 PM.

What is the 52 Week High and Low of Marksans Pharma Ltd?

Answer Field

The 52 Week High and Low of Marksans Pharma Ltd for NSE is ₹ 270.70 and ₹ 156.00 and for BSE is ₹ 270.60 and ₹ 157.25.

What is 1 year return for Marksans Pharma Ltd?

Answer Field

The 1 year returns on the stock has been -13.75%.

What is the P/E Ratio of Marksans Pharma Ltd Share?

Answer Field

As on Apr 13 2026 03:30 PM the price-to-earnings (PE) ratio for Marksans Pharma Ltd share is 0.0.

What is the PB ratio of Marksans Pharma Ltd Share?

Answer Field

As on Apr 13 2026 03:30 PM, the price-to-book (PB) ratio for Marksans Pharma Ltd share is 0.0.

How to Buy Marksans Pharma Ltd Share?

Answer Field

You can trade in Marksans Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Marksans Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Marksans Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Marksans Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

Who is the CEO of Marksans Pharma Ltd?

Answer Field

Marksans Pharma Ltd is led by Mr. Mark Saldanha, who serves as the Managing Director and Chief Executive Officer of the company. Under his leadership, the company has expanded its presence in the global pharmaceutical market and achieved significant growth in various regions. Mr. Saldanha’s vision has been instrumental in driving the company’s strategic acquisitions, as well as in its research and development initiatives.

When was Marksans Pharma established?

Answer Field

Marksans Pharma Ltd was initially incorporated as Tasc Pharmaceuticals Limited in April 1982. Following a Scheme of Amalgamation, the company’s name was changed to Marksans Pharma Ltd on 10th October 2005. The rebranding marked the beginning of the company’s expanded focus on pharmaceutical formulations, and since then, it has become a prominent player in the pharmaceutical sector.

What factors influence the Marksans Pharma Share Price?

Answer Field

The Marksans Pharma share price is influenced by several key factors, including:

  • The company’s financial performance, including revenue growth, net profit, and earnings per share (EPS)
  • Acquisitions and R&D activities
  • Strong revenue and profit growth that boosts investor confidence
  • Successful product launches and US FDA approvals
  • Expanding R&D facilities
  • Broader pharmaceutical market trends and regulatory changes
  • Global economic factors impacting stock performance

Is Marksans Pharma debt-free?

Answer Field

Marksans Pharma Ltd is not entirely debt-free. However, the company has maintained a manageable level of debt as part of its capital structure. It strategically acquires businesses and invests in research and development to fuel its growth. The debt levels are often monitored to ensure they do not adversely impact the company's financial health. Despite this, the company has successfully maintained profitability and strong cash flow, helping it manage its liabilities efficiently.

What is the CAGR of Marksans Pharma Share?

Answer Field

The Marksans Pharma share price has demonstrated a Compound Annual Growth Rate (CAGR) of:

  • 20% over the last 10 years
  • 87% over the last 5 years
  • 72% over the last 3 years
  • 96% over the past year

This impressive growth rate highlights the company’s consistent performance and the market’s positive response to its strategic initiatives, including acquisitions and expanding its product portfolio.

How has the Marksans Pharma Share Price performed over the past year?

Answer Field

Over the past year, the Marksans Pharma share price has seen a remarkable increase of 96%. This surge in share price reflects strong financial performance, successful product approvals, and the company's continued expansion in both domestic and international markets. The robust growth in the past year has also been fueled by investor confidence, supported by strategic acquisitions such as Tevapharm India and the company's increasing presence in the global pharmaceutical industry.

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59